Today is Tuesday, Jul. 7, 2020

Department of Internal Medicine

Hematology & Oncology

Photo of  Elyse Lower, MD

Elyse Lower, MD

Professor of Medicine, Director, UCCI Comprehensive Breast Cancer Program and Director, Medical Oncology

Clinical Interest

Medical Oncology
Hematology and Oncology

Specialties

Internal Medicine
Medical Oncology

Education/Credentials
  • Bachelor's Degree: Baylor University
  • Medical Degree: University of Cincinnati
  • Residency: University of Cincinnati Medical Center
  • Fellowship: University of Cincinnati
  • Master's Degree: Baylor University
Board Certifications & Licenses
  • American Board of Internal Medicine 09/12/1984
  • American Board of Internal Medicine (Medical Oncology) 11/07/1989
Contact Information
  • Holmes Hospital
  • Eden Avenue and Albert Sabin Way, Room 1001
  • ML 0565
  • Cincinnati, Ohio 45267
  • Office 513-584-3810
  • Fax 513-584-5110
  • Email elyse.lower@uc.edu
  • UC Institute Member Seal

Peer Reviewed Publications

Hunt, Brian G; Wicker, Christina A; Bourn, Jennifer R; Lower, Elyse E; Takiar, Vinita; Waltz, Susan E 2020. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients. Breast cancer research and treatment, 181 3, 529-540

Kittaneh, Muaiad; Badve, Sunil; Caldera, Humberto; Coleman, Robert; Goetz, Matthew P; Mahtani, Reshma; Mamounas, Eleftherios; Kalinsky, Kevin; Lower, Elyse; Pegram, Mark; Press, Michael F; Rugo, Hope S; Schwartzberg, Lee; Traina, Tiffany; Vogel, Charles 2020. Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical breast cancer, ,

Rahaghi, Franck F; Baughman, Robert P; Saketkoo, Lesley Ann; Sweiss, Nadera J; Barney, Joseph B; Birring, Surinder S; Costabel, Ulrich; Crouser, Elliott D; Drent, Marjolein; Gerke, Alicia K; Grutters, Jan C; Hamzeh, Nabeel Y; Huizar, Isham; Ennis James, W; Kalra, Sanjay; Kullberg, Susanna; Li, Huiping; Lower, Elyse E; Maier, Lisa A; Mirsaeidi, Mehdi; Müller-Quernheim, Joachim; Carmona Porquera, Eva M; Samavati, Lobelia; Valeyre, Dominique; Scholand, Mary Beth 2020. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. European respiratory review : an official journal of the European Respiratory Society, 29 155,

Rahaghi, Franck F; Sweiss, Nadera J; Saketkoo, Lesley Ann; Scholand, Mary Beth; Barney, Joseph B; Gerke, Alicia K; Lower, Elyse E; Mirsaeidi, Mehdi; O'Hare, Lanier; Rumbak, Mark J; Samavati, Lobelia; Baughman, Robert P 2020. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. European respiratory review : an official journal of the European Respiratory Society, 29 155,

Shlobin, Oksana A; Kouranos, Vasilis; Barnett, Scott D; Alhamad, Esam H; Culver, Daniel A; Barney, Joseph; Cordova, Francis C; Carmona, Eva M; Scholand, Mary Beth; Wijsenbeek, Marlies; Ganesh, Sivagini; Lower, Elyse E; Engel, Peter J; Wort, John; Price, Laura; Wells, Athol U; Nathan, Steven D; Baughman, Robert P 2020. Physiological Predictors of Survival in Patients with Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry. The European respiratory journal, ,

Sweiss, Nadera J; Korsten, Peter; Syed, Huzaefah; Syed, Aamer; Baughman, Robert P; Yee, Arthur M F; Culver, Daniel A; Sosenko, Teresa; Azuma, Arata; Bonella, Francesco; Costabel, Ulrich; Drake, Wonder P; Drent, Marjolein; Lower, Elyse E; Israel-Biet, Dominique; Mostard, Remy L M; Nunes, Hilario; Rottoli, Paola; Spagnolo, Paolo; Wells, Athol U; Wuyts, Wim A; Judson, Marc A 2020. When the Game Changes: Guidance to Adjust Sarcoidosis Management During the COVID-19 Pandemic. Chest, ,

Lower, Elyse E; Sturdivant, Madison; Grate, Lisa; Baughman, Robert P 2019. Use of third-line therapies in advanced sarcoidosis. Clinical and experimental rheumatology, ,

Mahtani, Reshma; Holmes, Frankie-Ann; Badve, Sunil; Caldera, Humberto; Coleman, Robert; Mamounas, Eleftherios; Kalinsky, Kevin; Kittaneh, Muaiad; Lower, Elyse; Pegram, Mark; Press, Michael F; Rugo, Hope S; Schwartzberg, Lee; Vogel, Charles 2019. A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer. Clinical breast cancer, ,

Abraham, Jame; Caldera, Humberto; Coleman, Robert; Elias, Anthony; Goetz, Matthew P; Kittaneh, Muaiad; Lower, Elyse; Mahtani, Reshma; Terry Mamounas, E; Pegram, Mark; Rugo, Hope; Schwartzberg, Lee; Traina, Tiffany; Vogel, Chuck 2018. Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast cancer research and treatment, 169 1, 1-7

Abraham, Jame; Coleman, Robert; Elias, Anthony; Holmes, Frankie Ann; Kalinsky, Kevin; Kittaneh, Muaiad; Lower, Elyse; Mahtani, Reshma; Terry Mamounas, E; Pegram, Mark; Vogel, Charles 2018. Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG). Breast cancer research and treatment, 171 1, 11-20

Baughman, Robert P; Lower, Elyse E 2018. Steroids for sarcoidosis: How much and for how long? Respiratory medicine, 138S , S5-S6

Baughman, Robert P; Lower, Elyse E; Kirkil, Gamze 2018. Response. Chest, 153 6, 1507-1508

Baughman, Robert P; Shlobin, Oksana A; Wells, Athol U; Alhamad, Esam H; Culver, Daniel A; Barney, Joseph; Cordova, Francis C; Carmona, Eva M; Scholand, Mary Beth; Wijsenbeek, Marlies; Ganesh, Sivagini; Birring, Surinder S; Kouranos, Vasilis; O'Hare, Lanier; Baran, Joanne M; Cal, Joseph G; Lower, Elyse E; Engel, Peter J; Nathan, Steven D 2018. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Respiratory medicine, 139 , 72-78

Bickett, Alexandra N; Lower, Elyse E; Baughman, Robert P 2018. Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis. Chest, 154 5, 1052-1060

Kirkil, Gamze; Lower, Elyse E; Baughman, Robert P 2018. Predictors of Mortality in Pulmonary Sarcoidosis. Chest, 153 1, 105-113

Lower, Elyse E; Charif, Mahmoud; Bartelt, Meg 2018. Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study. Cancer chemotherapy and pharmacology, 82 1, 165-170

Walaszek, Kinga; Lower, Elyse E; Ziolkowski, Piotr; Weber, Georg F 2018. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis. British journal of cancer, 119 10, 1259-1266

Yang, Yongguang; Leonard, Marissa; Zhang, Yijuan; Zhao, Dan; Mahmoud, Charif; Khan, Shugufta; Wang, Jiang; Lower, Elyse E; Zhang, Xiaoting 2018. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1. Cancer research, 78 2, 422-435

Baughman, Robert P; Sweiss, Nadera; Keijsers, Ruth; Birring, Surinder S; Shipley, Ralph; Saketkoo, Lesley Ann; Lower, Elyse E 2017. Repository corticotropin for Chronic Pulmonary Sarcoidosis. Lung, 195 3, 313-322

Freeman, C M; Xia, B T; Wilson, G C; Lewis, J D; Khan, S; Lee, S J; Lower, E E; Edwards, M J; Shaughnessy, E A 2017. Idiopathic granulomatous mastitis: A diagnostic and therapeutic challenge. American journal of surgery, 214 4, 701-706

Lower, Elyse E; Khan, Shagufta; Kennedy, Diane; Baughman, Robert P 2017. Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site. Breast cancer (Dove Medical Press), 9 , 515-520

Ruiz-Torres, Sasha J; Benight, Nancy M; Karns, Rebekah A; Lower, Elyse E; Guan, Jun-Lin; Waltz, Susan E 2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical ?-catenin signaling. Oncotarget, 8 35, 58918-58933

Zhou, Ying; Lower, Elyse E; Li, Hui-Ping; Costea, Alexandru; Attari, Mehran; Baughman, Robert P 2017. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest, 151 1, 139-148

Zhou, Ying; Lower, Elyse E; Li, Huiping; Farhey, Yolanda; Baughman, Robert P 2017. Clinical characteristics of patients with bone sarcoidosis. Seminars in arthritis and rheumatism, 47 1, 143-148

Baughman, Robert P; Barney, Joseph B; O'Hare, Lanier; Lower, Elyse E 2016. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respiratory medicine, 110 , 66-72

Baughman, Robert P; Judson, Marc A; Lower, Elyse E; Drent, Marjolein; Costabel, Ulrich; Flavin, Susan; Lo, Kim Hung; Barnathan, Elliot S 2016. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 32 4, 289-95

Zhou, Ying; Lower, Elyse E; Li, Huiping; Baughman, Robert P 2016. Clinical management of pulmonary sarcoidosis. Expert review of respiratory medicine, 10 5, 577-91

Zhou, Ying; Lower, Elyse E; Li, Huiping; Baughman, Robert P 2016. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel. Respiratory medicine case reports, 17 , 5-7

Baughman, Robert P; Culver, Daniel A; Jankovi, Vladimir; Fischkoff, Steven; Brockway, Giorgia; Lower, Elyse E 2015. Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 32 2, 106-14

Baughman, Robert P; Lower, Elyse E 2015. Treatment of Sarcoidosis. Clinical reviews in allergy & immunology, 49 1, 79-92

Baughman, Robert P; Lower, Elyse E 2015. Features of sarcoidosis associated with chronic disease. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 31 4, 275-81

Baughman, Robert P; Lower, Elyse E; Saketkoo, Lesley Ann 2015. Clinical trials in pulmonary sarcoidosis. Current opinion in pulmonary medicine, 21 5, 525-31

Baughman, Robert P; Culver, Daniel A; Cordova, Francis C; Padilla, Maria; Gibson, Kevin F; Lower, Elyse E; Engel, Peter J 2014. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial. Chest, 145 4, 810-817

Baughman, Robert P; Lower, Elyse E 2014. Medical therapy of sarcoidosis. Seminars in respiratory and critical care medicine, 35 3, 391-406

Carbone, Roberto G; Penna, Daniele; Baughman, Robert P; Lower, Elyse E 2014. Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis. Journal of clinical imaging science, 4 , 21

Baughman, R P; Janovcik, J; Ray, M; Sweiss, N; Lower, E E 2013. ??Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 30 2, 113-20

Baughman, Robert P; Lower, Elyse E 2013. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respiratory medicine, 107 12, 2009-13

Baughman, Robert P; Nunes, Hilario; Sweiss, Nadera J; Lower, Elyse E 2013. Established and experimental medical therapy of pulmonary sarcoidosis. The European respiratory journal, 41 6, 1424-38

Lower, Elyse E; Malhotra, Atul; Sudurlescu, Victoria; Baughman, Robert P 2013. Sarcoidosis, fatigue, and sleep apnea. Chest, 144 6, 1976-1977

Lower, Elyse E; Malhotra, Atul; Surdulescu, Victoria; Baughman, Robert P 2013. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. Journal of pain and symptom management, 45 2, 159-69

Baughman, R P; Drent, M; Culver, D A; Grutters, J C; Handa, T; Humbert, M; Judson, M A; Lower, E E; Mana, J; Pereira, C A; Prasse, A; Sulica, R; Valyere, D; Vucinic, V; Wells, A U 2012. Endpoints for clinical trials of sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 29 2, 90-8

Baughman, R P; Lower, E E; Ingledue, R; Kaufman, A H 2012. Management of ocular sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 29 1, 26-33

Baughman, Robert P; Lower, Elyse E; Gibson, Kevin 2012. Pulmonary manifestations of sarcoidosis. Presse medicale (Paris, France : 1983), 41 6 Pt 2, e289-302

Lower, Elyse E; Baughman, Robert P; Kaufman, Adam H 2012. Rituximab for refractory granulomatous eye disease. Clinical ophthalmology (Auckland, N.Z.), 6 , 1613-8

Baughman, R P; Nagai, S; Balter, M; Costabel, U; Drent, M; du Bois, R; Grutters, J C; Judson, M A; Lambiri, I; Lower, E E; Muller-Quernheim, J; Prasse, A; Rizzato, G; Rottoli, P; Spagnolo, P; Teirstein, A 2011. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 28 1, 56-64

Baughman, Robert P; Engel, Peter J; Taylor, Lisa; Lower, Elyse E 2010. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest, 138 5, 1078-85

Baughman, Robert P; Lower, Elyse E; Kaufman, Adam H 2010. Ocular sarcoidosis. Seminars in respiratory and critical care medicine, 31 4, 452-62

Baughman, Robert P; Lower, Elyse E; Tami, Thomas 2010. Upper airway. 4: Sarcoidosis of the upper respiratory tract (SURT). Thorax, 65 2, 181-6

Baughman, R P; Judson, M A; Lower, E E; Highland, K; Kwon, S; Craft, N; Engel, P J 2009. Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 26 2, 110-20

de Kleijn, W P E; Elfferich, M D P; De Vries, J; Jonker, G J; Lower, E E; Baughman, R P; King, T E; Drent, M 2009. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 26 2, 92-7

Lower, Elyse E; Fleishman, Stewart; Cooper, Alyse; Zeldis, Jerome; Faleck, Herbert; Yu, Zhinuan; Manning, Donald 2009. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. Journal of pain and symptom management, 38 5, 650-62

Lower, Elyse E; Glass, Eleanor; Blau, Robbin; Harman, Stacy 2009. HER-2/neu expression in primary and metastatic breast cancer. Breast cancer research and treatment, 113 2, 301-6

Baughman, Robert P; Judson, Marc A; Teirstein, Alvin; Lower, Elyse E; Lo, Kim; Schlenker-Herceg, Rozsa; Barnathan, Elliot S 2008. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems. American journal of clinical dermatology, 9 3, 155-61

Lower, Elyse E; Harman, Stacy; Baughman, Robert P 2008. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest, 133 5, 1189-95

Lower, Elyse E; Weiss, Kenneth L 2008. Neurosarcoidosis. Clinics in chest medicine, 29 3, 475-92, ix

Baughman, Robert P; Lower, Elyse E 2007. Six-minute walk test in managing and monitoring sarcoidosis patients. Current opinion in pulmonary medicine, 13 5, 439-44

Baughman, Robert P; Lower, Elyse E 2007. Novel therapies for sarcoidosis. Seminars in respiratory and critical care medicine, 28 1, 128-33

Baughman, Robert P; Sparkman, Brian K; Lower, Elyse E 2007. Six-minute walk test and health status assessment in sarcoidosis. Chest, 132 1, 207-13

Lower, Elyse E; Esparaz, Benjamin T; Garnett, Sally A; Wade, James L 2007. Evaluation of fulvestrant in clinical practice: use of an electronic data registry. Clinical breast cancer, 7 7, 565-9

Baughman, Robert P; Engel, Peter J; Meyer, Cris A; Barrett, Amanda B; Lower, Elyse E 2006. Pulmonary hypertension in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 23 2, 108-16

Bradley, Deborah A; Lower, Elyse E; Baughman, Robert P 2006. Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 23 1, 58-65

Baughman, R P; Bradley, D A; Lower, E E 2005. Infliximab in chronic ocular inflammation. International journal of clinical pharmacology and therapeutics, 43 1, 7-11

Baughman, R P; Lower, E E 2005. Fungal infections as a complication of therapy for sarcoidosis. QJM : monthly journal of the Association of Physicians, 98 6, 451-6

Baughman, Robert P; Lower, Elyse E; Bradley, Deborah A; Raymond, Lawrence A; Kaufman, Adam 2005. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest, 128 2, 1062-47

Lower, Elyse E; Glass, Eleanor L; Bradley, Deborah A; Blau, Robbin; Heffelfinger, Sue 2005. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast cancer research and treatment, 90 1, 65-70

Baughman, Robert P; Lower, Elyse E 2004. Leflunomide for chronic sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 21 1, 43-8

Baughman, Robert P; Lower, Elyse E 2004. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. American journal of clinical dermatology, 5 6, 385-94

Baughman, Robert P; Koehler, Allison; Bejarano, Pablo A; Lower, Elyse E; Weber, Fredrick L 2003. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Archives of internal medicine, 163 5, 615-20

Baughman, Robert P; Lower, Elyse E; du Bois, Roland M 2003. Sarcoidosis. Lancet (London, England), 361 9363, 1111-8

Lower, Elyse E; Drosick, D Randolph; Blau, Robbin; Brennan, Lawrence; Danneman, William; Hawley, Douglas K 2003. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clinical breast cancer, 4 2, 114-9

Baughman, Robert P; Iannuzzi, Michael C; Lower, Elyse E; Moller, David R; Balkissoon, Ronald C; Winget, Donna B; Judson, Marc A 2002. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 19 3, 198-204

Baughman, Robert P; Judson, Marc A; Teirstein, Alvin S; Moller, David R; Lower, Elyse E 2002. Thalidomide for chronic sarcoidosis. Chest, 122 1, 227-32

Baughman, Robert P; Lower, Elyse E 2002. Therapy for extrapulmonary sarcoidosis. Seminars in respiratory and critical care medicine, 23 6, 589-96

Baughman, Robert P; Lower, Elyse E 2002. Can persistent tumor necrosis factor release lead to refractory sarcoidosis? Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 19 3, 164-6

Bernstein, Jonathan A; Garramone, Stephen M; Lower, Elise G 2002. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 89 2, 212-4

Rohatgi, Nitin; Blau, Robbin; Lower, Elyse E 2002. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. Journal of women's health & gender-based medicine, 11 3, 291-301

Safal, Malek; Lower, Elyse E; Hasselgren, P O; Hungness, Eric S; Gazder, Paula; Aron, Bernard; Shaughnessy, Elizabeth A; Yassin, Rawia 2002. Bilateral synchronous breast cancer and HER-2/neu overexpression. Breast cancer research and treatment, 72 3, 195-201

Wobus, Manja; Rangwala, Reshma; Sheyn, Irena; Hennigan, Robert; Coila, Brigit; Lower, Elyse E; Yassin, Rawia S; Sherman, Larry S 2002. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Applied immunohistochemistry & molecular morphology : AIMM, 10 1, 34-9

Baughman, R P; Lower, E E 2001. Infliximab for refractory sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 1, 70-4

Baughman, R P; Ohmichi, M; Lower, E E 2001. Combination therapy for sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 2, 133-7

Lower, E E; Hawkins, H H; Baughman, R P 2001. Breast disease in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 3, 301-6

Baughman, R P; Winget, D B; Lower, E E 2000. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 17 1, 60-6

Hungness, E S; Safa, M; Shaughnessy, E A; Aron, B S; Gazder, P A; Hawkins, H H; Lower, E E; Seeskin, C; Yassin, R S; Hasselgren, P O 2000. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery, 128 4, 702-7

Baughman, R P; Lower, E E 1999. A clinical approach to the use of methotrexate for sarcoidosis. Thorax, 54 8, 742-6

Baughman, R P; Lower, E E; Miller, M A; Bejarano, P A; Heffelfinger, S C 1999. Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 16 1, 57-61

Lower, E E; Blau, R; Gazder, P; Stahl, D L 1999. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast cancer research and treatment, 58 3, 205-11

Lower, E E; Blau, R; Gazder, P; Tummala, R 1999. The risk of premature menopause induced by chemotherapy for early breast cancer. Journal of women's health & gender-based medicine, 8 7, 949-54

Baughman, R P; Lower, E E 1997. Steroid-sparing alternative treatments for sarcoidosis. Clinics in chest medicine, 18 4, 853-64

Baughman, R P; Lower, E E 1997. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 2, 121-30

Baughman, R P; Winget, D B; Bowen, E H; Lower, E E 1997. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 2, 154-8

Lower, E E; Broderick, J P; Brott, T G; Baughman, R P 1997. Diagnosis and management of neurological sarcoidosis. Archives of internal medicine, 157 16, 1864-8

Turner, G A; Lower, E E; Corser, B C; Gunther, K L; Baughman, R P 1997. Sleep apnea in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 1, 61-4

Wright, P S; Loudy, D E; Cross-Doersen, D E; Montgomery, L R; Sprinkle-Cavallo, J; Miller, J A; Distler, C M; Lower, E E; Woessner, R D 1997. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. Experimental and molecular pathology, 64 1, 41-51

Heffelfinger, S C; Lower, E E; Miller, M A; Fenoglio-Preiser, C M 1996. Plasma membrane phosphotyrosine, Her2-NEU, and epidermal growth factor receptor in human breast cancer. A comparative study. American journal of clinical oncology, 19 6, 552-7

Heffelfinger, S C; Yassin, R; Miller, M A; Lower, E 1996. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clinical cancer research : an official journal of the American Association for Cancer Research, 2 11, 1873-8

Lower, E E; Baughman, R P 1995. Prolonged use of methotrexate for sarcoidosis. Archives of internal medicine, 155 8, 846-51

Lower, E E; Miller, M A; Williams, L; Westermann, C; Heffelfinger, S 1995. Increased phosphotyrosine in breast cancer tissue is associated with a worse prognosis. Breast cancer research and treatment, 35 3, 277-82

O'Brien, G M; Baughman, R P; Broderick, J P; Arnold, L; Lower, E E 1994. Paranoid psychosis due to neurosarcoidosis. Sarcoidosis, 11 1, 34-6

Baughman, R P; Lower, E E; Flessa, H C; Tollerud, D J 1993. Thrombocytopenia in the intensive care unit. Chest, 104 4, 1243-7

Lower, E E; Franco, R S; Miller, M A; Martelo, O J 1993. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens. Breast cancer research and treatment, 26 3, 217-24

Baughman, R P; Lower, E E 1992. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest, 102 4, 1090-4

Lower, E E; Baughman, R P 1992. Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis. Chest, 102 4, 1113-7

Lower, E E; Franco, R S; Martelo, O J 1992. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias. The American journal of the medical sciences, 303 6, 387-91

Pavelic, Z P; Pavelic, L; Lower, E E; Gapany, M; Gapany, S; Barker, E A; Preisler, H D 1992. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer research, 52 9, 2597-602

Baughman, R P; Lower, E E 1991. An inhibitor of tumor necrosis factor found in pleural effusions. The Journal of laboratory and clinical medicine, 118 4, 326-31

Baughman, R P; Shipley, R T; Loudon, R G; Lower, E E 1991. Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis. Chest, 100 1, 96-101

Baughman, R P; Lower, E E 1990. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. The American review of respiratory disease, 142 6 Pt 1, 1268-71

Baughman, R P; Strohofer, S A; Buchsbaum, J; Lower, E E 1990. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. The Journal of laboratory and clinical medicine, 115 1, 36-42

Lower, E E; Baughman, R P 1990. The use of low dose methotrexate in refractory sarcoidosis. The American journal of the medical sciences, 299 3, 153-7

Lower, E E; Baughman, R P 1990. The effect of cancer and chemotherapy on monocyte function. Journal of clinical & laboratory immunology, 31 3, 121-5

Baughman, R P; Doers, J; Lower, E E; Buchsbaum, J 1989. Isolation of functionally active pleural macrophages. Journal of clinical & laboratory immunology, 30 3, 147-51

Baughman, R P; Lower, E E; Pierson, G; Strohofer, S 1988. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. The Journal of laboratory and clinical medicine, 111 4, 399-404

Lower, E E; Smith, J T; Martelo, O J; Baughman, R P 1988. The anemia of sarcoidosis. Sarcoidosis, 5 1, 51-5

Lower, E E; Strohofer, S; Baughman, R P 1988. Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide. The American journal of the medical sciences, 295 3, 193-7

Pelstring, R J; Kim, C K; Lower, E E; Swerdlow, S H 1988. Marrow granulomas in coal workers' pneumoconiosis. A histologic study with elemental analysis. American journal of clinical pathology, 89 4, 553-6

Baughman R.; Lower E.; Sturdivant M. 12-18-2019. Presence of onconeural antibodies in sarcoidosis patients with parasarcoidosis syndrome Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36 4, 254-260

Baughman R.; Engel P.; Lower E. 12-01-2009. Sarcoidosis Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide, , 213-242

Baughman R.; Lower E. 12-01-2009. Sarcoidosis A Clinician's Pearls and Myths in Rheumatology, , 409-420

Barnard J.; Baughman R.P.; Bresnitz E.A.; Brown K.; Brown S.; Canner M.; Cherniack R.; Cosentino M.; D'Alessandro S.; Daniele R.; Dayton C.; DePalo L.; Deshler J.; Dotson J.; Finn P.; Frederick M.; Garpestad E.; Heister N.; Hunninghake G.; Iannuzzi M.C.; Johns C.J.; Johnson T.; Judson M.A.; Knatterud G.L.; Lackland D.T.; Lesser M.; Lindenfelser S.; LoPresti F.; Lower E.E.; Magira E.; Major M.; Maliarik M.; Marshall M.; McLennan G.; Moller D.R.; Monos D.; Moran A.; Musson R.; Newman L.S.; Padilla M.L.; Pandey J.P.; Popovich J.; Powers L.; Rabin D.L.; Rand C.; Regovich J.; Rose C.; Rossman M.D.; Rybicki B.A.; Sahn S.; Sexauer W.; Sorlie P.; Steimel J.; Stein S.; Strange C.; Teirstein A.S.; Terrin M.L.; Thompson B.; Thompson B.W.; Weinberger S.E.; Wilkins P.; Winget D.B.; Wu M.; Yeager H. 12-01-2008. HLA and environmental interactions in sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases, 25 2, 125-132

Baughman R.; Drent M.; Lower E. 12-01-2008. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them Sarcoidosis Vasculitis and Diffuse Lung Diseases, 25 2, 76-89

Budd G.; Erban J.; Hutchins L.; Jones S.; Laufman L.; Lower E.; Mennel R.; Meyers M.; Olsen S.; Overmoyer B.; Pritchard K.; Ravdin P.; Richards D.; Sundaram S.; Urba W. 12-01-2005. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer Journal of Clinical Oncology, 23 24, 5542-5551

Amin B.; Chen Y.M.; Gradishar W.J.; Hill T.; Iqbal S.; Lower E.E.; Marcom P.K.; Meza L.A.; Samid D. 12-01-2004. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multi Women's Oncology Review, 4 4, 283-285

Amin B.; Chen Y.M.; Gradishar W.J.; Hill T.; Lower E.E.; Marcom P.K.; Meza L.A.; Samid D. 12-01-2004. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multi Journal of Clinical Oncology, 22 12, 2321-2327

Baughman R.; Lower E. 12-01-2002. Therapy for extrapulmonary sarcoidosis Seminars in Respiratory and Critical Care Medicine, 23 6, 589-596

Dukor R.; Johnson B.; Lower E.; Marcott C.; Story G.; Yassin R. 12-01-2002. Infrared spectroscopic imaging looking for diagnostic chemical markers Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings, 2 , 1145-1146

Baughman R.; Bowen E.; Lower E.; Winget D. 12-01-1998. Predicting respiratory failure in sarcoidosis patients Pneumologie, 52 1, 33

Baughman R.; Lower E. 12-01-1998. Alternatives to corticosteroids in the treatment of sarcoidosis Pneumologie, 52 1, 33

Baughman R.; Corser B.; Gunther K.; Lower E.; Turner G. 12-01-1997. Sleep apnoe in sarcoidosis Pneumologie, 51 9, 924

Baughman R.; Lower E.; Winget D. 12-01-1992. The long term use of methotrexate in patients with chronic symptomatic sarcoidosis Sarcoidosis, 9 SUPPL. 1, 465-466

Baughman R.; Lower E.; Winget D. 12-01-1992. The long term use of methotrexate in patients with chronic symptomatic sarcoidosis Sarcoidosis, 9 SUPPL. 1, 465-466

Baughman R.; Costabel U.; Lower E. 11-01-2012. Drug therapy for interstitial lung disease Diffuse Lung Disease: A Practical Approach: Second Edition, 9781441997715 , 101-120

Baughman R.; Engel P.; Lower E.; Taylor L. 11-01-2010. Survival in sarcoidosis-associated pulmonary hypertension: The importance of hemodynamic evaluation Chest, 138 5, 1078-1085

Baughman R.; Kaufman A.; Lower E. 10-04-2012. Rituximab for refractory granulomatous eye disease Clinical Ophthalmology, 6 1, 1613-1618

Alessandro S.D.; Almenoff P.; Ashikaga T.; Barnard J.; Baughman R.; Baughman R.P.; Bresnitz E.A.; Brett I.; Brown K.; Brown S.; Canner M.; Cherniack R.; Cherniak R.; Cosentino M.; Coultas D.B.; Daniele R.; Davis G.S.; Dayton C.; DePalo L.; Deshler J.; Dotson J.; Finn P.; Frederick M.; Garpestad E.; Gifford F.; Heister N.; Hunninghake G.; Iannuzzi M.C.; Jaffe R.D.; Johns C.J.; Johnson T.; Judson M.A.; Knatterud G.L.; Kotzin B.; Lackland D.T.; Lee C.W.; Lesser M.; Lindenfelser S.; LoPresti F.; Lower E.E.; Major M.; Maliarik M.; Marshall M.; Martin W.; McLennan G.; Moller D.; Moller D.R.; Monos D.; Moran A.; Musson R.; Musson R.A.; Newman L.; Newman L.S.; Padilla M.L.; Pandey J.; Popovich J.; Powers L.; Rabin D.L.; Rand C.; Regovich J.; Rose C.; Rossman M.; Rossman M.D.; Rybicki B.A.; Sahn S.; Sexauer W.; Sorlie P.; Steimel J.; Stein S.; Strange C.; Teirstein A.S.; Terrin M.L.; Thompson B.W.; Tian X.; Weinberger S.E.; Wilkins P.; Winget D.B.; Wu M.; Yeager H.; Zheng G. 09-30-2006. Robust trend tests for genetic association using matched case-control design Statistics in Medicine, 25 18, 3160-3173

Barnard J.; Baughman R.P.; Bresnitz E.A.; Brown K.; Brown S.; Canner M.; Cherniack R.; Cosentino M.; D'Alessandro S.; Daniele R.; Dayton C.; DePalo L.; Deshler J.; Dotson J.; Du Bois R.M.; Fingerlin T.E.; Finn P.; Frederick M.; Garpestad E.; Heister N.; Hunninghake G.; Iannuzzi M.C.; Johns C.J.; Johnson T.; Jonth A.C.; Judson M.A.; Knatterud G.L.; Lackland D.T.; Lesser M.; Lindenfelser S.; LoPresti F.; Lower E.E.; Luby J.C.; Maier L.A.; Major M.; Maliarik M.; Marshall M.; Martyny J.; McCammon C.; McLennan G.; Moller D.R.; Moran A.; Musson R.; Newman L.; Newman L.S.; Padilla M.L.; Pandey J.; Popovich J.; Powers L.; Rabin D.L.; Rand C.; Regovich J.; Rose C.; Rose C.S.; Rossman M.D.; Rybicki B.A.; Sahn S.; Sato H.; Sexauer W.; Silveira L.; Sorlie P.; Steimel J.; Stein S.; Strange C.; Teirstein A.S.; Terrin M.L.; Thompson B.W.; Weinberger S.E.; Welsh K.I.; Wilkins P.; Winget D.B.; Wu M.; Yeager H. 09-15-2007. TGF-?1 variants in chronic beryllium disease and sarcoidosis Journal of Immunology, 179 6, 4255-4262

Baughman R.; Lower E. 09-01-2017. Measuring sarcoidosis around the world: Using the same ruler Revista Portuguesa de Pneumologia (English Edition), 23 5, 247-248

Baughman R.; De Kleijn W.; De Vries J.; Drent M.; Elfferich M.; Lower E. 09-01-2009. Fatigue in sarcoidosis: A systematic review Current Opinion in Pulmonary Medicine, 15 5, 499-506

Baughman R.; Lower E. 08-17-2017. Sarcoidosis-associated pulmonary hypertension: Diagnosis and treatment Pulmonary Hypertension and Interstitial Lung Disease, , 129-143

Baughman R.; Kennedy D.; Khan S.; Lower E. 08-02-2017. Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and Breast Cancer: Targets and Therapy, 9 , 515-520

Baughman R.; Lower E. 07-07-2009. Diagnosis of Pneumonia in Immunocompromised Patient Pulmonary Infection in the Immunocompromised Patient: Strategies for Management, , 53-93

De Vries J.; Drent M.; Lower E. 07-01-2012. Sarcoidosis-associated fatigue European Respiratory Journal, 40 1, 255-263

Baughman R.; Favus M.; Korsten P.; Lower E.; Niewold T.; Sweiss N. 06-01-2011. Bone health issues in sarcoidosis Current Rheumatology Reports, 13 3, 265-272

Baughman R.; Lower E. 06-01-2011. Who dies from sarcoidosis and why? American Journal of Respiratory and Critical Care Medicine, 183 11, 1446-1447

Baughman R.; Lower E. 05-23-2014. Goldilocks, vitamin D and sarcoidosis Arthritis Research and Therapy, 16 3,

Baughman R.P.; Dudek S.; Finn P.W.; Garcia J.G.N.; Lower E.E.; Mirsaeidi M.; Perkins D.; Sweiss N.J. 05-01-2014. Rituximab in the treatment of refractory pulmonary sarcoidosis European Respiratory Journal, 43 5, 1525-1528

Baughman R.; Lower E. 05-01-2004. New therapies for sarcoidosis Clinical Pulmonary Medicine, 11 3, 154-160

Baughman R.; Lower E. 05-01-2003. The variability of sarcoidosis: Can we predict it? Chest, 123 5, 1329-1332

Baughman R.; Lower E. 04-29-1998. Treatment of sarcoidosis with corticosteroids: Who is going to relapse and why? Sarcoidosis Vasculitis and Diffuse Lung Disease, 15 1, 19-20

Baughman R.; Lower E. 04-19-2016. Immunosuppressive and cytotoxic drug therapy for diffuse ILD Interstitial Pulmonary and Bronchiolar Disorders, , 119-161

Baughman R.; Dudvarski-Ilic A.; Filipovic S.; Gvozdenovic B.; Lower E.; Mihailovic-Vucinic V.; Omcikus M.; Popevic S.; Stjepanovic M.; Videnovic-Ivanov J.; Vukovic M.; Zugic V. 04-01-2013. Effect of obesity on patient-reported outcomes in sarcoidosis International Journal of Tuberculosis and Lung Disease, 17 4, 559-564

Baughman R.; Lower E.; Qin Y.; Sweiss N.; Tillinger M. 03-21-2019. A composite score to assess treatment response in pulmonary sarcoidosis: The sarcoidosis treatment S Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36 1, 86-88

Baughman R.; Lower E. 02-15-2012. Sarcoidosis mortality American Journal of Respiratory and Critical Care Medicine, 185 4, 462

Baughman R.; Craft N.; Ingledue R.; Judson M.; Lower E. 02-01-2012. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis Archives of Dermatology, 148 2, 262-264

Badve S.; Caldera H.; Coleman R.; Goetz M.P.; Kalinsky K.; Kittaneh M.; Lower E.; Mahtani R.; Mamounas E.; Pegram M.; Press M.F.; Rugo H.S.; Schwartzberg L.; Traina T.; Vogel C. 01-01-2020. Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Clinical Breast Cancer, ,

Badve S.; Caldera H.; Coleman R.; Holmes F.A.; Kalinsky K.; Kittaneh M.; Lower E.; Mahtani R.; Mamounas E.; Pegram M.; Press M.F.; Rugo H.S.; Schwartzberg L.; Vogel C. 01-01-2020. A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Clinical Breast Cancer, ,

Benight N.; Guan J.; Karns R.; Lower E.; Ruiz-Torres S.; Waltz S. 01-01-2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canoni Oncotarget, 8 35, 58918-58933

Baughman R.P.; Li H.; Lower E.E.; Zhou Y. 01-01-2016. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel Respiratory Medicine Case Reports, 17 , 5-7

Aubart F.C.; Azuma A.; Bandyopadhyay D.; Baughman R.; Baughman R.P.; Bernie D.; Carmona E.; Chapelon C.; Costabel U.; Crouser E.; Culver D.; Culver D.A.; Drent M.; Gelfand J.; Gross A.; Grutters J.C.; Gupta D.; Hamzeh N.; Hoitsma E.; Inoue Y.; Ishihara M.; Israel-Biet D.; Judson M.A.; Koth L.; Li H.P.; Lower E.; Lower E.E.; Maier L.; Matragrano A.P.; Morgenthau A.S.; Morimoto S.; Neto M.R.; Nozaki K.; Patterson K.; Prasse A.; Rittoli P.; Rosenbach M.; Rossman M.; Rottoli P.; Sahoo D.; Shigemitsu H.; Shijubo N.; Soskel N.; Stern B.; Sweiss N.; Tavee J.; Valeyre D.; Vedantham V.; Wells A.; Westney G.; Yamaguchi T.; Yee A. 01-01-2014. The WASOG sarcoidosis organ assessment instrument: An update of a previous clinical tool Sarcoidosis Vasculitis and Diffuse Lung Diseases, 31 1, 19-27

Baughman R.; Carbone R.; Lower E.; Penna D. 01-01-2014. Accuracy of serial PET-CT imaging in systemic sarcoidosis Journal of Clinical Imaging Science, 4 1,

Baughman R.; Gibson K.; Lower E. 01-01-2012. Pulmonary manifestations of sarcoidosis Presse Medicale, 41 6 PART 2,

Baughman R.; Lower E.; Tami T. 01-01-2010. Upper airway.4: Sarcoidosis of the upper respiratory tract (SURT) Thorax, 65 2, 181-186

De Vries J.; Drent M.; Lower E. 01-01-2010. Quality of life in sarcoidosis: Assessment and management Seminars in Respiratory and Critical Care Medicine, 31 4, 485-493

Baughman R.; Harman S.; Lower E. 01-01-2008. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis- Chest, 133 5, 1189-1195

Esparaz B.; Garnett S.; Lower E.; Wade J. 01-01-2007. Evaluation of fulvestrant in clinical practice: Use of an electronic data registry Clinical Breast Cancer, 7 7, 565-569

Baughman R.; Lower E. 01-01-2005. Future direction of therapy for sarcoidosis Sarcoidosis, , 785-800

Lower E. 01-01-2005. Rare forms of sarcoidosis Sarcoidosis, , 651-670

Blau R.; Brennan L.; Danneman W.; Drosick D.; Hawley D.; Lower E. 01-01-2003. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival Clinical Breast Cancer, 4 2, 114-119

Baughman R.; Lower E. 01-01-2001. Erratum: Infliximab for refractory sarcoidosis (Sarcoidosis Vasculitis and Diffuse Lung Disease (Mar Sarcoidosis Vasculitis and Diffuse Lung Diseases, 18 3, 310

Bismayer J.; Blau R.; Brennan L.; Broun R.; Danneman W.; Drosick D.; Hawley D.; Lower E. 01-01-2001. Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin Breast Cancer Research and Treatment, 69 3, 271

Almenoff P.; Barnard J.; Baughman R.; Bowen E.H.; Bresnitz E.; Brown S.; Dayton C.; DePalo L.; Dow D.; Finn P.; Hunningshake G.; Iannuzzi M.; Johns C.; Johns C.J.; Johnson T.; Judson M.A.; Knatterud G.L.; Lackland D.T.; Lesser M.; Lower E.E.; Major M.; Maliarik M.; Marshall M.; McLennan G.; Moller D.; Moller D.R.; Moran A.; Musson R.; Newman L.S.; Pandey J.; Popovich J. J.; Rabin D.; Rabin D.L.; Rand C.; Rose C.; Rossman M.D.; Rybicki B.; Sahn S.; Sexauer W.; Steimel J.; Stein S.; Strange C.; Strutzman J.; Teirstein A.; Terrin M.L.; Thompson B.W.; Weinberger S.; Weiss S.T.; Winget D.B.; Yeager H. J. 01-01-1999. Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS) Journal of Clinical Epidemiology, 52 12, 1173-1186

Baughman R.; Lower E. 01-01-1999. New treatment for sarcoidosis: Where's the proof? European Respiratory Journal, 14 5, 1000-1001

Baughman R.; Lower E. 01-01-1996. Immunosuppressant therapy for idiopathic pulmonary fibrosis Clinical Immunotherapeutics, 6 6, 431-442

Baughman R.; Lower E. 01-01-1996. Immunosuppressant therapy for idiopathic pulmonary fibrosis Clinical Immunotherapeutics, 6 6, 431-442

Baughman, R P; Gunther, K L; Buchsbaum, J A; Lower, E E . Prevalence of digital clubbing in bronchogenic carcinoma by a new digital index. Clinical and experimental rheumatology, 16 1, 21-6

Baughman, R P; Lower, E E . Measuring sarcoidosis around the world: Using the same ruler. Revista portuguesa de pneumologia, 23 5, 247-248

Baughman, Robert P; Lower, Elyse E . Evidence-based therapy for cutaneous sarcoidosis. Clinics in dermatology, 25 3, 334-40

Heffelfinger, S C; Yassin, R; Miller, M A; Lower, E E . Cyclin D1, retinoblastoma, p53, and Her2/neu protein expression in preinvasive breast pathologies: correlation with vascularity. Pathobiology : journal of immunopathology, molecular and cellular biology, 68 3, 129-36

Lower, Elyse E; Khan, Shagufta . Biomarker discordance: why it occurs and why it is important. Cancer biomarkers : section A of Disease markers, 12 6, 219-30